Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion

R Franco, S Zappavigna, V Gigantino, A Luce, M Cantile, M Cerrone, G Facchini, S Perdonà, S Pignata, G Di Lorenzo, S Chieffi, G Vitale, M De Sio, Alessandro Sgambato, G Botti, Am Yousif, E Novellino, P Grieco, M. Caraglia*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolopeer review

26 Citazioni (Scopus)

Abstract

Non Muscle Invasive Bladder Transitional Cancer (NMIBC) and Muscle Invasive Bladder Transitional Cancer (MIBC)/invasive have different gene profile and clinical course. NMIBC prognosis is not completely predictable, since the relapse rate is higher than 20%, even in the form of MIBC. The aim of this study is to evaluate if UTR expression can discriminate between NMIBC and MIBC and predict the risk of relapses in NMIBCs.
Lingua originaleInglese
pagine (da-a)N/A-N/A
Numero di pagine1
RivistaJournal of Experimental and Clinical Cancer Research
Volume33
Numero di pubblicazione1
DOI
Stato di pubblicazionePubblicato - 2014

All Science Journal Classification (ASJC) codes

  • Oncologia
  • Ricerca sul Cancro

Keywords

  • Adult
  • Aged
  • Carcinoma
  • Cell Line
  • Cell Movement
  • Cell Proliferation
  • Disease-Free Survival
  • Female
  • G-Protein-Coupled
  • Gene Expression
  • Humans
  • Kaplan-Meier Estimate
  • Local
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Recurrence
  • Peptide Fragments
  • Prognosis
  • Receptors
  • Tissue Array Analysis
  • Transitional Cell
  • Tumor
  • Urinary Bladder Neoplasms
  • Urotensins

Fingerprint

Entra nei temi di ricerca di 'Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion'. Insieme formano una fingerprint unica.

Cita questo